Human factors testing of the levodopa-carbidopa intestinal gel delivery system in advanced Parkinson's disease patients and healthcare providers

被引：0
|
作者：
Rodriguez, Ramon
Fernandez, Hubert
Espay, Alberto
Conjeevaram, Rajkumar
Zhou, Ji
Kuntz, Matthew
Halpern, Edward
Benesh, Janet
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
76
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [21] Efficacy of levodopa-carbidopa intestinal GEL infusion on advanced Parkinson's disease patients at our hospital
    Sakata, M.
    Hiwatani, Y.
    Matsumoto, T.
    Minamino, M.
    Hironishi, M.
    Ito, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 728 - 728
  • [22] Stable levodopa plasma levels with jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Nyholm, D.
    Odin, P.
    Johansson, A.
    Chatamra, K.
    Locke, C.
    Freeman, S.
    Dutta, S.
    Othman, A. A.
    MOVEMENT DISORDERS, 2012, 27 : S131 - S131
  • [23] Comment on: “Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review”
    Andrew T. Lambarth
    CNS Drugs, 2016, 30 : 1007 - 1008
  • [24] Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review"
    Lambarth, Andrew T.
    CNS DRUGS, 2016, 30 (10) : 1007 - 1008
  • [25] Efficacy of Levodopa-Carbidopa Intestinal Gel Versus Oral Levodopa-Carbidopa in Advanced Parkinson's: Sensitivity and Responder Analyses
    Boyd, James T.
    Fernandez, Hubert H.
    Slevin, John T.
    Espay, Alberto J.
    Standaert, David G.
    Pritchett, Yili
    Zhang, Wuyan
    Chatamra, Krai
    Widnell, Katherine L.
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2013, 74 : S44 - S44
  • [26] Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel
    Solla, Paolo
    Cannas, Antonino
    Marrosu, Maria Giovanna
    Marrosu, Francesco
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (11) : 1383 - 1384
  • [27] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
    K. Ray Chaudhuri
    A. Simon Pickard
    Ali Alobaidi
    Yash J. Jalundhwala
    Prasanna L. Kandukuri
    Yanjun Bao
    Julia Sus
    Glynn Jones
    Christian Ridley
    Julia Oddsdottir
    Seyavash Najle-Rahim
    Matthew Madin-Warburton
    Weiwei Xu
    Anette Schrag
    PharmacoEconomics, 2022, 40 : 559 - 574
  • [28] Long-Term Safety of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Rodriguez, Ramon L.
    Schmulewitz, Nathan
    Hall, Coleen
    Eaton, Susan
    Dubow, Jordan
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2014, 76 : S46 - S46
  • [29] Weight, BMI, and Dyskinesia in Patients With Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel
    Pontieri, F.
    Bourgeois, P.
    Chaudhuri, K.
    Siddiqui, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Simu, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 230 - 230
  • [30] The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England
    Chaudhuri, K. Ray
    Pickard, A. Simon
    Alobaidi, Ali
    Jalundhwala, Yash J.
    Kandukuri, Prasanna L.
    Bao, Yanjun
    Sus, Julia
    Jones, Glynn
    Ridley, Christian
    Oddsdottir, Julia
    Najle-Rahim, Seyavash
    Madin-Warburton, Matthew
    Xu, Weiwei
    Schrag, Anette
    PHARMACOECONOMICS, 2022, 40 (05) : 559 - 574
12345